Sign up for free psoriasis treatment tips by email.

EMAIL ADDRESS:


Find us on Facebook




Latest News

SEE ALLOur Sponsors

Archive for the ‘Side-effects of treatment’ Category

Abbott withdraws application to market briakinumab for psoriasis

January 15th 2011 | Biologics, Psoriasis Research, Side-effects of treatment | 13 Comments
Be Sociable, Share!

Abbott today announced in a securities filing that it has withdrawn its application with the U.S. Food and Drug Administration (FDA) and European regulators to market its much-anticipated, experimental

Briakinumab (ABT-874) Phase Three psoriasis trial results bring joy, concern

October 11th 2010 | Biologics, Psoriasis Research, Side-effects of treatment, Treatment | 11 Comments
Be Sociable, Share!

[UPDATE 1/14/2011: Abbott today announced that it has withdrawn its application with the U.S. FDA to market briakinumab (ABT-874, Ozespa). Our full analysis of Abbott's pulling its briakinumab application is here. Our original, unedited post concerning the Phase Three trials is below.] You know that buzz about Centocor Ortho Biotech’s biologic Stelara (ustekinumab), the first
READ THE FULL POST
© 2005-2013 Psoriasis Cure Now WEB DESIGN BY SKYHOOK MARKETING